BBSRC Portfolio Analyser
Award details
Prion therapeutics from traditional Chinese herbs
Reference
BBS/E/I/00001203
Principal Investigator / Supervisor
Dr Andrew Gill
Co-Investigators /
Co-Supervisors
Institution
The Pirbright Institute
Department
The Pirbright Institute Department
Funding type
Research
Value (£)
3,047
Status
Completed
Type
Institute Project
Start date
01/08/2004
End date
31/07/2007
Duration
36 months
Abstract
In this proposal two parallel and highly interactive programmes are proposed. In the screening programme, further optimisation and validation of the test platform as a primary screening tool is required. Also a series of secondary screening techniques based on Western blotting, conformational dependant immunoassay, ligand bind assay, PrP conversion assay and cell culture study are proposed to further validate the ELISA-based primary screening technique and investigate the mode of drug action of the hits found in herbal extracts. At the same time, the chemistry programme will focus on the fractionation and separation to identify the active ingredients in the herbal extract identified through the primary and secondary screening. Efforts will be made to broaden the selection of the herbs from traditional herbs to rare herbal species, to investigate the extraction and separation chemistry, and to chemically synthesise the active compounds in order to speed up the identification of lead compounds.
Summary
unavailable
Committee
Closed Committee - Biomolecular Sciences (BMS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search